InMed Pharmaceuticals Inc ( INM ) shares are trading higher by 22.6% to $6.05 during Tuesday’s session after the company announced that INM-901 reduced Alzheimer’s-related inflammation in a preclinical study.

What To Know: The study revealed a significant reduction in markers of neuroinflammation, a key driver of Alzheimer's progression. Treatment with INM-901 led to a dose-dependent decrease in pro-inflammatory cytokines like TNF-α, IL-1ß, and INF-γ, which are linked to tissue inflammation.

Additionally, high-dose treatments significantly reduced levels of neurofilament light chain, a biomarker indicative of neuronal damage in neurodegenerative diseases.

Complementary mRNA profiling confirmed decreases in neuroinflammatory genes such as GFAP, CD-33, and TLR-2, which align with the observed improvements.

Read Also: Apple’s AI Advances Can’t Offset Chinese Market Slowdown, Says Analyst

How To Buy INM Stock

By now you're likely curious about how to participate in the market for InMed Pharmaceuticals ( INM ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

In the case of InMed Pharmaceuticals ( INM ), which is trading at $4.95 as of publishing time, $100 would buy you 20.2 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

According to data from Benzinga Pro, INM has a 52-week high of $15.70 and a 52-week low of $2.41.